The 2010 Eurobarometer on the life sciences
@article{Gaskell2011The2E,
title={The 2010 Eurobarometer on the life sciences},
author={George Gaskell and Agnes Allansdottir and Nick Allum and Paula Castro and Yilmaz Esmer and Claude Fischler and Jonathan Jackson and Nicole Kronberger and J{\"u}rgen Hampel and Niels Mejlgaard and Alex Quintanilha and Andu Rammer and Gemma Revuelta and Sally Stares and Helge Torgersen and Wolfgang Wager},
journal={Nature Biotechnology},
year={2011},
volume={29},
pages={113-114}
}Since 1991, the triennial Eurobarometer survey has assessed public attitudes about biotech and the life sciences in Europe. The latest 2010 Eurobarometer survey on the Life Sciences and Biotechnology (http://ec.europa.eu/research/science-society/document_library/pdf_06/europeans-biotechnology-in-2010_en.pdf), based on representative samples from 32 European countries, hints at a new era in the relations between science and society. We see less criticism of technology based on distrust in…
106 Citations
Uncritical and unbalanced coverage of synthetic biology in the Nordic press
- Political SciencePublic understanding of science
- 2017
The press coverage of synthetic biology in the major Nordic countries between 2009 and 2014 was found to be event-driven and there were striking similarities between countries when it comes to framing, language use, and treated themes.
The status and prospects for genetically modified food in Europe and Croatia
- Business
- 2013
In the last sixteen years worldwide production of genetically modified (GM) crops has been increased sharply. At the same time, consumer‟s attitudes toward food products made from GM ingredients have…
The more favorable attitude of the citizens toward GMOs supports a new regulatory framework in the European Union
- EconomicsGM crops & food
- 2021
The steadily increasing acceptance of the EU citizens of GMOs in the environment and food, as it was recorded by Eurobarometers, should additionally ease the way and support a positive change of the legal framework that regulates the GM crops’ testing and commercial cultivation in the EU.
Genetically modified foods: bibliometric analysis on consumer perception and preference.
- BusinessGM crops & food
- 2022
ABSTRACT In this study, we present the bibliometric trends emerging from research outputs on consumer perception and preference for genetically modified (GM) foods and policy prescriptions for…
Public opinion toward GMOs and biotechnology in Bosnia and Herzegovina
- Medicine
- 2017
Although respondents were mainly introduced with the term “GMO”, most of them were not satisfied with their knowledge and available information considering biotechnology and its use, and displayed a pessimistic attitude which reflected a belief that the widespread use of GMOs is presenting a risk to human health and the environment.
The perception of biotechnology in agro-forestry: The opinion of undergraduates and researchers
- Economics
- 2017
Decomposing the effects of time on the social acceptability of biotechnology using age-period-cohort-country models
- EconomicsPublic understanding of science
- 2017
Age-period-cohort-country models are estimated based on Eurobarometer data from 1991 onward to give similar results underlining the importance of the life-cycle effects as well as the heterogeneity of the link between political affiliation and biotechnologies attitudes across the European countries.
Religion and the public ethics of stem-cell research: Attitudes in Europe, Canada and the United States
- Political SciencePloS one
- 2017
It is found that the majority of people in Europe, Canada and the United States supported stem-cell research, providing it was tightly regulated, but that there were key differences between the geographical regions in the relative importance of different types of ethical position.
The Romanian experience and perspective on the commercial cultivation of genetically modified crops in Europe
- Medicine, BiologyTransgenic Research
- 2018
The Court of Justice of the European Union ruled that plants obtained with the new gene editing techniques must go through the same authorization procedure as transgenic plants, which is expected to delay the approval and availability of these new plant varieties on the EU market and their commercial cultivation.